Abstract:Focal nodular hyperplasia (FNH) and hepatocellular adenomas (HCAs) constitute benign hepatic neoplasms in adults. HCAs are monoclonal neoplasms characterised by an increased predilection to haemorrhage and also malignant transformation. On the other hand, FNH is a polyclonal tumour-like lesion that occurs in response to increased perfusion and has an uneventful clinical course. Recent advances in molecular genetics and genotype-phenotype correlation in these hepatocellular neoplasms have enabled a new classification system. FNHs are classified into the typical and atypical types based on histomorphological and imaging features. HCAs have been categorised into four subtypes: (1) HCAs with HNF-1α mutations are diffusely steatotic, do not undergo malignant transformation, and are associated with familial diabetes or adenomatosis. (2) Inflammatory HCAs are hypervascular with marked peliosis and a tendency to bleed. They are associated with obesity, alcohol and hepatic steatosis. (3) HCAs with β-catenin mutations are associated with male hormone administration and glycogen storage disease, frequently undergo malignant transformation and may simulate hepatocellular carcinoma on imaging. (4) The final type is unclassified HCAs. Each of these except the unclassified subtype has a few distinct imaging features, often enabling reasonably accurate diagnosis. Biopsy with immunohistochemical analysis is helpful in difficult cases and has strong implications for patient management.Teaching points• FNHs are benign polyclonal neoplasms with no risk of haemorrhage or malignancy.• HCAs are benign monoclonal neoplasms classified into four subtypes based on immunohistochemistry.• Inflammatory HCAs show an atoll sign with a risk of bleeding and malignant transformation.• HNF-1α HCAs are steatotic HCAs with minimal complications and the best prognosis.• β-Catenin HCA shows variable MRI features and a high risk of malignancy.

Hepatocellular adenoma: Where are we now?

Hepatocellular Adenoma Update: Diagnosis, molecular Classification, and Clinical Course

Hepatocellular adenoma: An unsolved diagnostic enigma

A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma

[Hepatocellular adenoma: update 2020]

Hepatocellular adenoma: what we know, what we do not know, and why it matters

Hepatocellular adenoma: Review of contemporary diagnostic and therapeutic options

Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach

Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update.

Hepatocellular Neoplasm of Uncertain Potential of Malignancy or Well-Differentiated Hepatocellular Carcinoma Arising within Hepatocellular Adenoma

New insights in the management of Hepatocellular Adenoma

Benign Tumors of the Liver and Intrahepatic Bile Duct

Retrospective Study of Hepatocellular Adenomas Based on the Phenotypic Classification System: A Report from China.

Systematic review of hepatocellular adenoma in China and other regions

Hepatobiliary Mucinous Cystadenoma and Cystadenocarcinoma: Report of Six Cases and Review of the Literature.

Hepatocellular Adenoma and Liver Adenomatosis: a Report of 11 Patients

Diagnostic challenges and risk stratification of hepatocellular adenoma

Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma

Hepatocellular Adenoma with Malignant Transformation in Male Patients with Non-Cirrhotic Livers

Hepatocellular Adenoma and Focal Nodular Hyperplasia

Hepatocellular Adenoma With Hepatocyte Nuclear Factor-1 Alpha (HNF-1α) Mutation: A Case Report